The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Neurobiology of nicotine dependence
Open accessAbstract
Nicotine is a psychoactive ingredient in tobacco that significantly contributes to the harmful tobacco smoking habit. Nicotine dependence is more prevalent than dependence on any other substance. Preclinical research in animal models of the various aspects of nicotine dependence suggests a critical role of glutamate, γ-aminobutyric acid (GABA), cholinergic and dopamine neurotransmitter interactions in the ventral tegmental area and possibly other brain sites, such as the central nucleus of the amygdala and the prefrontal cortex, in the effects of nicotine. Specifically, decreasing glutamate transmission or increasing GABA transmission with pharmacological manipulations decreased the rewarding effects of nicotine and cue-induced reinstatement of nicotine seeking. Furthermore, early nicotine withdrawal is characterized by decreased function of presynaptic inhibitory metabotropic glutamate 2/3 receptors and increased expression of postsynaptic glutamate receptor subunits in limbic and frontal brain sites, while protracted abstinence may be associated with increased glutamate response to stimuli associated with nicotine administration. Finally, adaptations in nicotinic acetylcholine receptor function are also involved in nicotine dependence. These neuroadaptations probably develop to counteract the decreased glutamate and cholinergic transmission that is hypothesized to characterize early nicotine withdrawal. In conclusion, glutamate, GABA and cholinergic transmission in limbic and frontal brain sites are critically involved in nicotine dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.2.3.244 · Cited by 1,341
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740 · cited 1×
“…data, behavioural data indicated that injections of the competitive nAChR antagonist DHbE into the VTA but not into the nucleus accumbens (Corrigall et al. 1994), or lesions of the mesolimbic dopaminergic projections from the VTA to the nucleus accumbens (Corrigall et al. 1992), or…”
BackgroundSynaptic mechanisms underlie nicotine-induced excitability of brain reward areas
Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2002) · Neuron · doi:10.1016/s0896-6273(02)00625-6 · Cited by 701 · cited 2×
“Hence, these receptors offer unique opportunities to alter in pharmacologically subtle ways glutamate transmission, and thus affect motivated behaviour and affective processes without producing gross undesirable or toxic side effects (Markou 2007).”
BackgroundNicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization
Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., Whiteaker, P., Marks, M. J., Collins, A. C., & Lester, H. A. (2004) · Science · doi:10.1126/science.1099420 · Cited by 686
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
Self-citationThe scientific case that nicotine is addictive
Stolerman, I. P., & Jarvis, M. J. (1995) · Psychopharmacology · doi:10.1007/bf02245088 · Cited by 649
Acetylcholine Receptor: An Allosteric Protein
Changeux, J.-P., Devillers-Thiéry, A., & Chemouilli, P. (1984) · Science · doi:10.1126/science.6382611 · Cited by 623
Molecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551
Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in Vivo
Schwartz, R. D., & Kellar, K. J. (1983) · Science · doi:10.1126/science.6828889 · Cited by 479
Effects of chronic nicotine infusion on tolerance development and nicotinic receptors
Marks, M. J., Burch, J. B., & Collins, A. C. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21831-6 · Cited by 464
Desensitization of neuronal nicotinic receptors
Quick, M. W., & Lester, R. A. J. (2002) · Journal of Neurobiology · doi:10.1002/neu.10109 · Cited by 456
Cellular and synaptic mechanisms of nicotine addiction
Mansvelder, H. D., & McGehee, D. S. (2002) · Journal of Neurobiology · doi:10.1002/neu.10148 · Cited by 440
Moran, M. M., McFarland, K., Melendez, R. I., Kalivas, P. W., & Seamans, J. K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1007-05.2005 · Cited by 411
Weiner, I. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1313-x · Cited by 391
Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies
Perry, D. C., Dávila-Garcı́a, M. I., Stockmeier, C. A., & Kellar, K. J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38304-1 · Cited by 362
Chronic Exposure to Nicotine Upregulates the Human α4β2 Nicotinic Acetylcholine Receptor Function
Buisson, B., & Bertrand, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01819.2001 · Cited by 361
The paradox of nicotinic acetylcholine receptor upregulation by nicotine
Wonnacott, S. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90242-z · Cited by 357
Nicotinic receptor subtypes and cognitive function
Levin, E. D. (2002) · Journal of Neurobiology · doi:10.1002/neu.10151 · Cited by 354
Neurobiology of the nicotine withdrawal syndrome
Kenny, P. J., & Markou, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00651-7 · Cited by 310 · cited 1×
“The avoidance of these withdrawal syndromes, as well as the positive subjective effects of nicotine, motivates nicotine use (Kenny & Markou 2001).”
BackgroundSelf-citationKlitenick, M., DeWitte, P., & Kalivas, P. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02623.1992 · Cited by 309
Selective dopamine antagonists reduce nicotine self-administration
Corrigall, W. A., & Coen, K. M. (1991) · Psychopharmacology · doi:10.1007/bf02244174 · Cited by 281
Chaudhri, N., Caggiula, A. R., Donny, E. C., Palmatier, M. I., Liu, X., & Sved, A. F. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0178-1 · Cited by 271
Conditioned Withdrawal Drives Heroin Consumption and Decreases Reward Sensitivity
Kenny, P. J., Chen, S. A., Kitamura, O., Markou, A., & Koob, G. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0740-06.2006 · Cited by 267
Self-citationKenny, P. J., & Markou, A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300905 · Cited by 261
Self-citationPicciotto, M. R., & Corrigall, W. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03338.2002 · Cited by 261
Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials
Shiffman, S., West, R., & Gilbert, D. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200410001734067 · Cited by 255 · cited 1×
“Thus, within hours upon cessation of nicotine exposure, a nicotine withdrawal syndrome emerges characterized by depressed mood, irritability, mild cognitive deficits and physiological symptoms (Shiffman et al. 2004).”
BackgroundNicotine addiction: the possible role of functional upregulation
Buisson, B., & Bertrand, D. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01979-9 · Cited by 254
Acetaldehyde Enhances Acquisition of Nicotine Self-Administration in Adolescent Rats
Belluzzi, J. D., Wang, R., & Leslie, F. M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300586 · Cited by 247
The ups and downs of addiction: role of metabotropic glutamate receptors
Kenny, P. J., & Markou, A. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.009 · Cited by 223
Self-citationThe mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice
Paterson, N. E., Semenova, S., Gasparini, F., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1432-z · Cited by 220
Self-citationWatkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214 · cited 2×
“Similar reward deficits are seen when nAChR antagonists are administered to rats that are chronically treated with nicotine, while the same doses of the nAChR antagonists have no effect in control vehicle-treated rats (Epping-Jordan et al. 1998; Watkins et al. 2000).”
BackgroundSelf-citationCryan, J. F., Kelly, P. H., Chaperon, F., Gentsch, C., Mombereau, C., Lingenhoehl, K., Froestl, W., Bettler, B., Kaupmann, K., & Spooren, W. P. J. M. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066753 · Cited by 206
A novel strategy for the treatment of cocaine addiction
Dewey, S. L., Morgan, A. E., Ashby, C. R., Horan, B., Kushner, S. A., Logan, J., Volkow, N. D., Fowler, J. S., Gardner, E. L., & Brodie, J. D. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2<119::aid-syn1>3.0.co;2-f · Cited by 195
Liechti, M. E., Lhuillier, L., Kaupmann, K., & Markou, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1766-07.2007 · Cited by 193
Self-citationDownregulation of nicotinic receptor function after chronic nicotine infusion.
Marks, M. J., Grady, S. R., & Collins, A. C. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39368-7 · Cited by 189
A pharmacologic strategy for the treatment of nicotine addiction
Dewey, S. L., Brodie, J. D., Gerasimov, M., Horan, B., Gardner, E. L., & Ashby, C. R. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199901)31:1<76::aid-syn10>3.0.co;2-y · Cited by 178
Corrigall, W., Coen, K. M., Adamson, K. L., Chow, B. L., & Zhang, J. (2000) · Psychopharmacology · doi:10.1007/s002139900355 · Cited by 171
Paterson, N. E., & Markou, A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2070-9 · Cited by 167
Self-citationA POTENTIAL ROLE FOR GABAB AGONISTS IN THE TREATMENT OF PSYCHOSTIMULANT ADDICTION
Brebner, K. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.5.478 · Cited by 166
Kenny, P. J., Chartoff, E. H., Roberto, M., Carlezon, W. A., & Markou, A. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.58 · Cited by 161
Self-citationMarkou, A., & Paterson, N. E. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110073380 · Cited by 154
Self-citationInfluences of Mood, Depression History, and Treatment Modality on Outcomes in Smoking Cessation.
Haas, A. L., Muñoz, R. F., Humfleet, G. L., Reus, V. I., & Hall, S. M. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.4.563 · Cited by 153
Fu, Y., Matta, S. G., Gao, W., Brower, V. G., & Sharp, B. M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39093-7 · Cited by 151
Harrison, A. A., Gasparini, F., & Markou, A. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0953-6 · Cited by 148
Self-citationFlores, C. M., Dávila‐García, M. I., Ulrich‐Lai, Y. M., & Kellar, K. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052216.x · Cited by 142
Kenny, P. J., Gasparini, F., & Markou, A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052027 · Cited by 140
Self-citationThe GABAB agonist baclofen modifies cocaine self-administration in rats.
Shoaib, M., SWANNER, L. S., Ce, B., Goldberg, & Schindler, C. W. (1998) · PubMed · Cited by 140
Bespalov, A., Драволина, О. А., Sukhanov, I., Захарова, Е., Blokhina, E. A., Zvartau, E. E., Danysz, W., Heeke, G. V., & Markou, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.007 · Cited by 137
Self-citationCrooks, P. A., & Dwoskin, L. P. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00117-2 · Cited by 135
The GABA B receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat
Paterson, N. E., Froestl, W., & Markou, A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1637-1 · Cited by 133
Self-citationNornicotine is self-administered intravenously by rats
Bardo, M. T., Green, T. A., Crooks, P. A., & Dwoskin, L. P. (1999) · Psychopharmacology · doi:10.1007/s002130051119 · Cited by 129
Long-term effects of chronic nicotine exposure on brain nicotinic receptors
Besson, M., Granon, S., Mameli-Engvall, M., Cloëz-Tayarani, I., Maubourguet, N., Cormier, A., Cazala, P., David, V., Changeux, J., & Fauré, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702698104 · Cited by 127
Lança, A. J., Adamson, K. L., Coen, K. M., Chow, B. L., & Corrigall, W. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00607-7 · Cited by 125
Paterson, N. E., Froestl, W., & Markou, A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300524 · Cited by 119
Self-citationSlattery, D. A., Markou, A., Froestl, W., & Cryan, J. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300734 · Cited by 118
Self-citationNisell, M., Marcus, M. M., Nomikos, G. G., & Svensson, T. H. (1997) · Journal of Neural Transmission · doi:10.1007/bf01271290 · Cited by 116
Nicotinic receptors, allosteric proteins and medicine
Changeux, J., & Taly, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.01.001 · Cited by 115
Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems
Kenny, P. J., & Markou, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4785-04.2005 · Cited by 107
Self-citationWang, F., Chen, H., Steketee, J. D., & Sharp, B. M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301033 · Cited by 102
Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1414-1 · Cited by 101
Self-citationBACLOFEN ANTAGONIZES INTRAVENOUS SELF-ADMINISTRATION OF NICOTINE IN MICE AND RATS
Fattore, L. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.5.495 · Cited by 100
Corrigall, W. A., Coen, K. M., Zhang, J., & Adamson, L. K. (2001) · Psychopharmacology · doi:10.1007/s002130100869 · Cited by 98
Paterson, N. E., Vlachou, S., Guery, S., Kaupmann, K., Froestl, W., & Markou, A. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139204 · Cited by 96
Self-citationEvidence for Functional Activity of Up‐Regulated Nicotine Binding Sites in Rat Striatal Synaptosomes
Rowell, P. P., & Wonnacott, S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05802.x · Cited by 84
Guillem, K., Vouillac‐Mendoza, C., Azar, M. R., Parsons, L. H., Koob, G. F., Cador, M., & Stinus, L. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05217.x · Cited by 68
Both GABAB receptor agonist and antagonists decreased brain stimulation reward in the rat
Macey, D. J., Froestl, W., Koob, G. F., & Markou, A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00204-5 · Cited by 59
Self-citationMarkou, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.053 · Cited by 58
Self-citationPerkins, K. A. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011951 · Cited by 55
Spontaneous Nicotine Withdrawal Potentiates the Effects of Stress in Rats
Jonkman, S., Risbrough, V. B., Geyer, M. A., & Markou, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301607 · Cited by 54
Self-citationGentry, C. L., Wilkins, L. H., & Lukas, R. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041756 · Cited by 53
Paterson, N. E., & Markou, A. (2002) · Synapse · doi:10.1002/syn.10073 · Cited by 41
Self-citationPaterson, N. E., Bruijnzeel, A. W., Kenny, P. J., Wright, C., Froestl, W., & Markou, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.031 · Cited by 21
Self-citationPharmacology of neuronal nicotinic acetylcholine receptors: Effect of acute and chronic nicotine
Kellar, K. J., Dávila‐García, M. I., & Xiao, Y. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011921 · Cited by 14
Cited by
Drugs as instruments: A new framework for non-addictive psychoactive drug use
Müller, C. P., & Schumann, G. (2011) · Behavioral and Brain Sciences · doi:10.1017/s0140525x11000057 · Cited by 286
Neural Systems Governed by Nicotinic Acetylcholine Receptors: Emerging Hypotheses
Miwa, J. M., Freedman, R., & Lester, H. A. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.014 · Cited by 205
Brain stimulation in the study and treatment of addiction
Feil, J., & Zangen, A. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.11.006 · Cited by 181
Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits
Mansvelder, H. D., Mertz, M., & Role, L. W. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.01.007 · Cited by 126
Schmaal, L., Berk, L., Hulstijn, K. P., Cousijn, J., Wiers, R. W., & van den Brink, W. (2011) · European Addiction Research · doi:10.1159/000327682 · Cited by 93
Metadata
- Authors
- Markou, A.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2008-07-18
- Volume
- 363
- Issue
- 1507
- Pages
- 3159-3168
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2123802262
- Cited by
- 268
- References
- 79
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.